English 
搜索
Hebei Lansheng Biotech Co., Ltd. ShangHai Yuelian Biotech Co., Ltd.

Red Sun to acquire 70% stake in Shandong Kexin Chemical for 72.80 million yuanqrcode

Dec. 20, 2016

Favorites Print
Forward
Dec. 20, 2016
Nanjing Red Sun announced on December 16 it will spend 72.80 million yuan to acquire a 70 percent stake in Shandong Kexin Chemical Ltd.
 
Shandong Kexin Chemical, a technology-oriented research, production and marketing enterprise, was established by Li Dejun, regarded as the Father of Chinese Paraquat. 
 
Shandong Kexin can annually produce 25,000 tons of ‘paraquat mother liquid 42 percent’ and also has the capability to develop and manufacture the product series that includes glufosinate, thiamethoxam, thiacloprid and tebufenozide.
 
Red Sun’s latest acquisition reflects its resource consolidation strategy. The acquisition of Kexin Chemical is expected to further entrench Red Sun in the paraquat business sector. With this, Red Sun will be able to reinforce its product range and industry chain that will help it realise the company’s five-year plan for expeditious growth and better integrate in the globalization process.
 
As of 30th November 2016, Shandong Kexin Chemical’s total assets (unaudited) stood at 159,987,651.17 yuan, with an asset-liability ratio of 23.87 percent. The operating income from January to November 2016 was 153,500,591.40 yuan, with a net profit of 2,532,010.54 yuan.
 
Source: AgroNews

0/1200

More from AgroNewsChange

Hot Topic More

I wanna post a press Comment

Subscribe 

Subscribe Email: *
Name:
Mobile Number:  

Comment  

0/1200

 

NEWSLETTER

Subscribe China Special Biweekly to send news related to your mailbox